top of page
The Longevity Edit
The Research
Worth Reading
Every Week
The week's most important research on longevity, health, and performance - carefully selected, clearly explained and delivered to your inbox.
Discover new clinical trials, expert perspectives, and evidence baed insights without spending hours researching journals, headlines, and conflicting health claims.
Complimentary for Bio Precision Aging Members.
One thoughtful edition each week. No noise, no hype, unsubscribe at anytime.
A failed Lp(a) trial and one that lowers LP(a) by 97%, a melanoma vaccine, the ketone your aging liver stops making, a gut bug that stretches healthspan, & more things worth your time this week.
Week of September 7th, 2026 The thread running through this week's research is subtraction: things your body quietly stops making, stops clearing, or starts making in the wrong place. We lead with a first-in-human trial in which a single injection knocked lipoprotein(a) down by up to 97% and held it there for nearly a year, then the phase 3 outcomes trial that spent seven years asking whether lowering that number actually prevents heart attacks and came back with an answer no
5 days ago15 min read
Calorie restriction's benefit traced to one immune protein, babies rationed off sugar had 69% less liver cancer, a shingles shot tracks with 24% less dementia, and four other things this week.
Week of August 31st, 2026 The thread running through this week's research is stubbornly consistent: aging looks less like machinery wearing out and more like an immune system that never quite stands down, and the interventions that matter are the ones that quiet it. We cover a Yale team that traced the anti-aging benefit of calorie restriction to a single immune protein made in your belly fat, a natural experiment from postwar Britain showing that sugar exposure before your s
Aug 2910 min read
Bowel cancer screening cuts death risk 43%, estrogen leaves fewer Alzheimer's plaques, your marrow quietly resupplies your brain, and four other things worth your time this week.
Week of August 24th, 2026 The thread running through this week's research is size: not whether something works, but how much, and how much of the headline number survives contact with an honest analysis. We cover a Swedish screening program that separates the benefit of getting the invitation from the benefit of actually mailing the kit back, autopsy data that complicates twenty years of warnings about estrogen and dementia, a genomic detective story showing that immune cells
Aug 219 min read
Semaglutide quiets heavy drinking, three minutes of daily vigor cuts cancer risk, a thymus hormone that reverses age-related inflammation — and four other things worth your time this week.
Week of August 17th, 2026 This week the research keeps pointing back to the body's own machinery: the hormones, brain rhythms, membrane lipids, and social wiring you already have, and how much of aging turns on whether they hold up. We cover a randomized trial testing whether semaglutide can quiet heavy drinking, a wearable study suggesting three minutes of daily huffing-and-puffing lowers cancer risk as much as an hour and a half of strolling, and a thymus hormone called thy
Aug 148 min read
A "natural Ozempic", the everyday sugar that helps cancer break free, a chewing gum that slashes cancer-linked HPV by 93%, and four other things worth your time this week.
Week of August 10th, 2026 The thread running through this week’s research is granularity: the field keeps zooming in, from whole organs down to single cells and single molecules, and finding that the action is at the fine scale. We cover a Stanford peptide just twelve amino acids long that curbs appetite like semaglutide but skips the nausea, a Wistar discovery that a common dietary sugar acts as a chemical "get loose and spread" signal to cancer cells, and a bioengineered ch
Aug 79 min read
bottom of page